Vectorite Biomedical Inc. (TPEX:4170)

Vectorite Biomedical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	21.39	25.71	30.6	25.32	27.87	39.2
Short-Term Investments	144.93	144.9	154.3	178.36	179.7	154.5
Trading Asset Securities	-	-	-	-	5.94	45.68
Cash & Short-Term Investments	166.32	170.61	184.9	203.67	213.52	239.38
Cash Growth	-5.88%	-7.73%	-9.21%	-4.61%	-10.80%	167.28%
Accounts Receivable	4.68	2.77	6.11	5.64	5.59	1.11
Other Receivables	0.49	0.42	0.46	0.06	0.16	0.76
Receivables	5.17	3.19	6.56	5.69	5.75	1.87
Inventory	16.95	14.97	14.79	10.04	4.83	7.24
Prepaid Expenses	1.44	3.1	2.22	-	7.97	1.84
Other Current Assets	-	0.01	-	3.73	-	-
Total Current Assets	189.87	191.89	208.47	223.13	232.06	250.32
Property, Plant & Equipment	169.54	172.7	172.4	178.33	182.73	190.7
Long-Term Investments	176.27	137.79	15.5	23.33	23.4	24.24
Other Intangible Assets	0.41	0.41	6.04	21.81	22.54	22.54
Other Long-Term Assets	1.93	6.77	10.36	5.51	5.1	4.85
Total Assets	538.02	509.56	412.78	452.1	465.82	492.65

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1.15	0.92	1.14	1.2	3.18	2.72
Accrued Expenses	-	8.48	6.05	7.02	4.85	6.39
Current Portion of Leases	0.18	0.18	-	-	-	-
Current Unearned Revenue	6.41	4.51	5.31	3.13	5.25	5.89
Other Current Liabilities	8.92	2.1	2.33	1.38	2.27	1.61
Total Current Liabilities	18.89	16.19	14.83	12.73	15.55	16.61
Long-Term Leases	0.12	0.21	-	-	-	-
Long-Term Unearned Revenue	7.97	8.07	8.16	8.51	8.93	9.09
Other Long-Term Liabilities	0.01	0.01	0.21	0.01	0.01	0.01
Total Liabilities	26.99	24.48	23.2	21.25	24.49	25.71

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	437.71	437.71	437.71	437.71	721.4	721.4
Additional Paid-In Capital	-	11.67	11.67	11.67	101.14	101.14
Retained Earnings	75.39	49.52	-46.65	-6.6	-373.17	-346.75
Comprehensive Income & Other	-2.45	-14.19	-13.56	-12.34	-8.48	-9.29
Total Common Equity	510.66	484.71	389.16	430.44	440.9	466.51
Minority Interest	0.37	0.37	0.42	0.41	0.44	0.43
Shareholders' Equity	511.03	485.08	389.58	430.85	441.34	466.94
Total Liabilities & Equity	538.02	509.56	412.78	452.1	465.82	492.65

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	0.3	0.39	-	-	-	-
Net Cash (Debt)	166.02	170.23	184.9	203.67	213.52	239.38
Net Cash Growth	-5.79%	-7.94%	-9.21%	-4.61%	-10.80%	167.28%
Net Cash Per Share	3.72	3.87	4.23	4.65	4.88	5.57
Filing Date Shares Outstanding	43.85	43.77	43.77	43.77	43.77	43.77
Total Common Shares Outstanding	43.85	43.77	43.77	43.77	43.77	43.77
Working Capital	170.98	175.7	193.64	210.4	216.52	233.71
Book Value Per Share	11.64	11.07	8.89	9.83	10.07	10.66
Tangible Book Value	510.25	484.3	383.12	408.63	418.36	443.97
Tangible Book Value Per Share	11.64	11.06	8.75	9.34	9.56	10.14
Land	-	59.45	59.45	59.45	59.45	59.45
Buildings	-	161.41	157.27	155.36	155.36	155.36
Machinery	-	43.38	60.92	59.99	55.23	54.34
Leasehold Improvements	-	-	2.5	2.5	2.5	2.5

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 26, 2026

Data Sources Report a data error